Korean J Clin Pharm.  2016 Jun;26(2):181-186. 10.0000/kjcp.2016.26.2.181.

Independent Data Monitoring Committees: Review of Current Guidelines

Affiliations
  • 1College of Pharmacy, Chungbuk National University, Cheongju 28644, Republic of Korea. kaylee@cbnu.ac.kr

Abstract

BACKGROUND
There has been on increasing emphasis on the importance of monitoring the safety of participants in a clinical trial to protect patients and maintain the integrity of the trial. The independent data monitoring committee (IDMC) has become common component of randomized clinical trials in recent years.
METHODS
It is important to consider the implications of different approaches that are being used in various countries. IDMC guidelines in Korea, US, and Europe were reviewed and compared to provide the objective, composition and operation of IDMC in detail.
RESULTS
IDMC is a group of experts in related subject are as who perform interim data monitoring to make a recommendation to the sponsor or organizer regarding appropriateness of trial continuation and the need for modifications of the trial. Independence of IDMC is preferred in order to minimize influence of factors unrelated to scientific, medical and ethical considerations that should underlie decision-making.
CONCLUSION
IDMC has become an increasingly important component of clinical trials in recent years. Practical operating procedures need to be developed considering the future regulatory status of data monitoring committees.

Keyword

Independent data monitoring committee; clinical trial; operation guideline

MeSH Terms

Clinical Trials Data Monitoring Committees*
Europe
Humans
Korea
Full Text Links
  • KJCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr